SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 116.43 |
Enterprise Value ($M) | 91.90 |
Book Value ($M) | 57.80 |
Book Value / Share | 0.33 |
Price / Book | 2.01 |
NCAV ($M) | 7.48 |
NCAV / Share | 0.04 |
Price / NCAV | 15.57 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.91 |
Return on Assets (ROA) | -0.64 |
Return on Equity (ROE) | -0.92 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.53 |
Current Ratio | 5.53 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 41.50 |
Assets | 91.83 |
Liabilities | 34.02 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 7.38 |
Operating Income | -83.35 |
Net Income | -82.47 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -70.45 |
Cash from Investing | 43.95 |
Cash from Financing | 15.24 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 4.63 | 0.36 | |
13G | Ra Capital Management, L.p. | 9.10 | ||
13G/A | BlackRock Inc. | 1.30 | -78.23 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
262,678 | 1,254,087 | 20.95 | |
298,011 | 1,859,441 | 16.03 | |
347,227 | 244,720 | 141.89 | |
233,459 | 242,163 | 96.41 | |
145,442 | 189,204 | 76.87 | |
(click for more detail) |
Similar Companies | |
---|---|
VSTM – Verastem, Inc. | VTGN – Vistagen Therapeutics, Inc. |
VTVT – vTv Therapeutics Inc. | VYNE – VYNE Therapeutics Inc. |
WINT – Windtree Therapeutics, Inc. |